Save time and jump to the most important pieces.
Submission status for BIOLINERX, LTD.'s drug APHEXDA (ORIG-1) with active ingredient MOTIXAFORTIDE has changed to 'Approval' on 09/08/2023. Application Category: NDA, Application Number: 217159, Application Classification: Type 1 - New Molecular Entity
HC Wainwright reiterated coverage of BioLineRx with a rating of Buy and set a new price target of $19.00 from $22.00 previously
HC Wainwright resumed coverage of BioLineRx with a rating of Buy
HC Wainwright & Co. reiterated coverage of BioLine Rx with a rating of Buy and set a new price target of $19.00 from $22.00 previously
6-K - BioLineRx Ltd. (0001498403) (Filer)
6-K - BioLineRx Ltd. (0001498403) (Filer)
6-K - BioLineRx Ltd. (0001498403) (Filer)